View Older Stories View More Recent Stories

Dec 19, 2019 04:45PM Amgen (AMGN), Allergan (AGN) Submit BLA For ABP 798, Biosimilar Candidate To Rituxan, to FDA
Dec 19, 2019 04:44PM Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan® (rituximab), To U.S. Food And Drug Administration
Dec 12, 2019 06:20AM Amgen (AMGN), UCB Announce EC Approves EVENITY for Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture
Dec 12, 2019 01:00AM European Commission Approves EVENITY® (romosozumab) For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Dec 11, 2019 04:00PM Amgen Announces 10% Increase In 2020 First Quarter Dividend
Dec 10, 2019 07:33AM Amgen (AMGN) Reports Data from Phase 3 CANDOR Study Combining KYPROLIS (carfilzomib) And DARZALEX
Dec 10, 2019 07:30AM Amgen Data From Phase 3 CANDOR Study Combining KYPROLIS® (carfilzomib) And DARZALEX® (daratumumab) To Be Presented During Late-Breaking Session At American Society Of Hematology Annual Meeting
Dec 9, 2019 09:00AM Amgen Selects Location For R&D Facility In The South San Francisco Biotechnology Hub
Dec 6, 2019 02:34PM Amgen (AMGN) Confirms FDA Approved its AVSOLA For Same Indications as Remicade
Dec 6, 2019 02:31PM FDA Approves Amgen's AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)
Dec 2, 2019 04:00PM Amgen Announces Data Being Presented At ASH 2019
Nov 21, 2019 06:26AM Amgen (AMGN) Completes Acquisition Of Otezla, Updates Guidance
Nov 21, 2019 06:21AM Amgen Completes Acquisition Of Otezla® (apremilast)
Nov 20, 2019 04:16PM Bristol-Myers Squibb (BMY) Completes Acquisition of Celgene (CELG)
Nov 20, 2019 04:16PM Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a Leading Biopharma Company
Nov 18, 2019 09:06AM Amgen (AMGN), Cytokinetics (CYTK) Announces New Results From COSMIC-HF Presented at AHA
Nov 18, 2019 09:00AM New Results From COSMIC-HF Presented At AHA 2019 Show Treatment Of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral Or Improved Measures Of Diastolic Function
Nov 18, 2019 09:00AM New Results From COSMIC-HF Presented at AHA 2019 Show Treatment of Heart Failure Patients With Omecamtiv Mecarbil Was Associated With Neutral or Improved Measures of Diastolic Function
Nov 16, 2019 09:00AM Amgen Announces New FOURIER Analysis Showing Benefit Of Repatha® (evolocumab) In High-Risk Patients Who Have Experienced A Recent Heart Attack
Nov 15, 2019 05:57PM Bristol-Myers (BMY) Receives FTC Clearance for Celgene (CELG) Acquisition, Deal Expected to Close Next Week
Nov 15, 2019 04:55PM Bristol-Myers Squibb Receives Clearance from U.S. Federal Trade Commission for Celgene Acquisition
Nov 15, 2019 09:00AM Amgen And The Duke Clinical Research Institute Announce Initiation Of First Large-Scale Registry To Evaluate Real-World Lipid Management And The Effectiveness Of PCSK9 Inhibitors
Nov 11, 2019 09:00AM Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio
Nov 7, 2019 05:01PM Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference
Oct 31, 2019 04:01PM Amgen (AMGN) will acquire 20.5% stake in BeiGene (BGNE) for approximately $2.7 billion in cash
Oct 31, 2019 04:00PM Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
Oct 30, 2019 06:00PM The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature
Oct 29, 2019 04:01PM Amgen Reports Third Quarter 2019 Financial Results
Oct 24, 2019 04:00PM Amgen Announces Webcast of 2019 Third Quarter Financial Results
Oct 24, 2019 09:01AM Amgen (AMGN) to Make Repatha Available Exclusively at Lower List Price Option
Oct 24, 2019 09:00AM Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Oct 23, 2019 04:00PM Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation
Oct 23, 2019 06:19AM Amgen (AMGN) CFO David Meline to Retire
Oct 22, 2019 07:22PM David Meline, Amgen's Chief Financial Officer, To Retire
Oct 22, 2019 04:00PM Amgen Announces 2019 Fourth Quarter Dividend
Oct 18, 2019 09:01AM Amgen (AMGN) Announces Nplate Now Approved For Earlier Use in Adults With Immune Thrombocytopenia
Oct 18, 2019 09:00AM Nplate® (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Oct 18, 2019 05:55AM Amgen (AMGN) Reports EVENITY (Romosozumab) Granted Positive CHMP Opinion for Treatment Of Severe Osteoporosis in Postmenopausal Women
Oct 18, 2019 01:00AM EVENITY® (Romosozumab) Receives Positive CHMP Opinion For The Treatment Of Severe Osteoporosis In Postmenopausal Women At High Risk Of Fracture
Oct 15, 2019 09:00AM Sports Anchor And Multiple Myeloma Patient Rod Gilmore Joins Amgen's Myeloma MVP™ Team
Oct 9, 2019 09:05AM Amgen Foundation Launches Amgen Biotech Experience In Pittsburgh
Sep 30, 2019 07:23AM Amgen (AMGN) Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO
Sep 28, 2019 01:00AM Amgen Announces New Clinical Data Evaluating Novel Investigational KRAS(G12C) Inhibitor In Patients With Solid Tumors At ESMO 2019
Sep 26, 2019 09:02AM Heart Attack Survivors Are Taking Steps To Reduce Their Cardiovascular Risk. But Are They The Right Ones?
Sep 25, 2019 04:00PM Amgen To Webcast Investor Call At ESMO 2019
Sep 24, 2019 04:02PM Amgen (AMGN) Reports Positive Results from Two Phase 3 BLINCYTO (blinatumomab) Studies Pediatric Patients with Relasped ALL
Sep 24, 2019 04:00PM Amgen Announces Positive Results From Two Phase 3 BLINCYTO® (blinatumomab) Studies In Pediatric Patients With Relapsed Acute Lymphoblastic Leukemia
Sep 17, 2019 04:00PM Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019
Sep 13, 2019 04:00PM Amgen To Present At The Bank of America Merrill Lynch Global Healthcare Conference
Sep 13, 2019 09:02AM Amgen (AMGN) Announces Phase 3 CANDOR Study Combining KYPROLIS And DARZALEX Meets Primary Endpoint of PFS
View More Recent Stories View Older Stories